UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

  

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 2, 2013

 

SYMMETRY MEDICAL INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Delaware   001-32374   35-1996126

(State or other jurisdiction

of incorporation)

   (Commission File Number)  

(IRS Employer

Identification No.)

 

3724 N State Road 15, Warsaw, Indiana 46582

(Address of Principal executive offices, including Zip Code)

 

(574) 268-2252

(Registrant’s telephone number, including area code)

  

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 2.02. Results of Operations and Financial Condition

 

On May 2, 2013, Symmetry Medical Inc. (“Symmetry”) issued a press release entitled, “Symmetry Medical Reports First Quarter 2013 Financial Results,” in which it announced its first fiscal quarter 2013 financial results.

  

A copy of this press release is being furnished as Exhibit 99.1.

 

Item 9.01. Financial Statements and Exhibits

 

(d)Exhibits

 

99.1“Symmetry Medical Reports First Quarter 2013 Financial Results,” Press Release issued by Symmetry Medical, Inc. dated May 2, 2013.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Symmetry Medical Inc.
   
  /s/ Fred L. Hite
Date: May 2, 2013 Name:  Fred L. Hite
  Title:    Chief Financial Officer

 

EXHIBIT INDEX

  

Exhibit

No.

   Description
     
99.1   “Symmetry Medical Reports First Quarter 2013 Financial Results,” Press Release issued by Symmetry Medical, Inc. dated May 2, 2013.